Skip to content
Search

Latest Stories

Pharmacy Business Diversity Conference - session summary: 'Gender diversity is crucial for businesses’ growth and performance'

The strength of any organization lies in its people. This being a common norm in the world of business, several of them are taking healthy initiatives and opening discussions around gender diversity and equality.

Panelists during a session on Empowering Women In the Workplace held during the Pharmacy Business Diversity Conference on Thursday (December 9), agreed that having gender diversity in business, not just benefits women, but the whole organization.


“It drives engagement, diversity of thinking and ultimately performance,” said Ifti Khan, pharmacy superintendent at Well Pharmacy, in the session moderated by the conference chair and BBC presenter Clive Myrie.

To substantiate his point, he cited a recent report by McKinsey & Company, as per which companies in the top quartile for ethnic and cultural diversity are 36 per cent more profitable than those in the fourth quartile.

He said: “Women make up such a large proportion of our workforce in the pharmacy industry, even more in patient facing roles. And so it's important for us to ensure women are engaged and empowered at work.”

Myrie observed that despite several initiatives by corporates, the dial for gender equity is not “moving as fast as it should be. It isn't moving as fast as the stats suggest,” causing a logjam.

Agreeing with Myrie’s comment, Silke Heinrichs Global D&I partner at Roche Diagnostics GmbH said a log jam still seems to be there, especially in company boards, footsie 100 firms, etc.

She said various root causes and stereotypes like “think manager think male” pose a big challenge in rectifying this.

She added that at the career front, women face a competitive disadvantage as a lot of caring related responsibilities still rest with women.

She highlighted that women do not have a level playing field in professional space as after childbirth they return to work mostly with 50 per cent time.

“And of course, it's very difficult to thrive and to shine and to get the coolest projects. If you're out for at least a year or longer, and then you return 50 per cent. It's difficult to progress in your career.”

To correct this situation, Heinrichs said, Roche has started a new initiative in September, under which the firm pays incentive if a new mothers returns earlier with more working hours per week and fathers reduce their working time to share the child care duty.

The idea is to influence society as a whole and bring a behavioural change.

Talking about initiatives at Well Pharmacy, Khan said: “We are in the process of developing our culture code. And over the last few months, we've approached everyone across the organisation to feed into that it's about core creation.”

It will give people an opportunity to come forward and express, he said.

Besides, the pharmacy chain has set up an inclusion working group involving colleagues from across the sector to develop a diversity and inclusion strategy.

“We're at the very early stages, but we've started on that journey, which is the most important thing,” Khan added.

During the discussion, Celeste Warren, vice president Global Diversity & Inclusion at Merck's Centre of Excellence noted that various life stages of women are very critical at the workplace, and it is the obligation of an organization to meet the needs of the women through these stages.

She informed that to understand such needs, Merck sends out a survey to employees.

Through this survey the company asks a “plethora of different questions and get that information back and then puts programmes in place,” she said.

Warren said these surveys are important to determine the needs of various dimensions of diversity that exist within the gender, based on sexuality, colour, disability, etc.

“If we don't take a multidimensional approach, we aren't going to meet the needs of gender parity. At MSD we are working very hard to try to create that gender inclusive environment,” Warren added.

More For You

Janet Morrison discusses pharmacy funding strategy at 2025 conference

Health Secretary Wes Streeting outlines government support for community pharmacy

CPE calls new funding deal a ‘reluctant yes’

Community Pharmacy England (CPE) was “reluctant” to accept the new pharmacy funding deal due to the significant funding gap, said the organisation’s chief executive Janet Morrison, while recognising the settlement as the first step towards stabilising the sector.

Addressing the 2025 Pharmacy Business Conference on Sunday at London Hilton Wembley, Janet shared insights into the behind-the-scenes work that led to the agreement.

Keep ReadingShow less
RPS transition to Royal College

RPS transition to Royal College: What it means for pharmacy

RPS transition to Royal College: What it means for pharmacy - Professor Claire Anderson explains

The Royal Pharmaceutical Society (RPS) is set to transition into a Royal College after securing majority support from its members in a recent ballot. However, concerns have been raised about the long-term implications of this shift.

With a voter turnout of 31.4%, 6,144 out of 19,594 eligible members participated in the vote on the Royal Charter changes. Of those, 71.1% supported the transition, well above the required two-thirds majority for a Special Resolution Vote.

Keep ReadingShow less
Pharmacies key to driving the shift from treatment to prevention

Bas Vorsteveld, Kenvue’s area managing director for Northern Europe.

Pharmacies can become frontline educators of self-care

Pharmacies have the potential to play a pivotal role in the government's transition from treatment-based healthcare to a more prevention-focused approach. However, for this shift to be successful, they require greater systemic support.

Bas Vorsteveld, Kenvue’s area managing director for Northern Europe, emphasises the importance of allowing pharmacists access to patient records to enable them to offer tailored advice and improve patient care.

Keep ReadingShow less
Community pharmacist consulting with a patient about independent prescribing.

Malcolm Harrison

Exclusive: National prescribing service 'critical' for community pharmacy, says Malcolm Harrison

A national prescribing service is “critical” for community pharmacy with all newly qualified pharmacists becoming independent prescribers from next year, according to Malcolm Harrison, chief executive of the Company Chemist Association (CCA).

“We are encouraging the NHS to work with community pharmacy to explore what that (prescribing service) could look like. There are pilots that are out there at the moment, and I know a number of pharmacies are engaged in those and exploring the different variations of what it could be,” Harrison told Pharmacy Business.

Keep ReadingShow less
Unlocking the potential of technology in pharmacy

Harry McQuillan, chairman, Numark

Technology in pharmacy goes beyond operational improvements

Community pharmacies are expected to take on greater responsibilities to ease pressure on other healthcare services and meet growing patient demands. However, despite their expanding role, they continue to lack adequate financial support.

“While funding negotiations continue, one thing remains clear, technology is key to ensuring pharmacy can thrive in a rapidly evolving healthcare landscape,” said Harry McQuillan, chairman of Numark.

Keep ReadingShow less